Isomorphic Labs
4 statements across 3 episodes · 3 bullish · 0 bearish · 3 people on the record · first statement May 10, 2024 by David Friedberg · said 19 times in 9 episodes since 2024 · across every show →
Mentions by year
brought up most by David Friedberg (10), Sundar Pichai (2), Chamath Palihapitiya (2), Dave Ricks (1)
tap a year for its mentions
2026 1 mention in 1 episode
2025 8 mentions in 4 episodes 2 per episode
- Inside Google DeepMind: AGI, Robotics, & World Models Explained - Demis Hassabis
- Sundar Pichai, CEO of Alphabet | The All-In Interview
- Which Company Is Going To Win The AI Race? - David Friedberg
- IPOs and SPACs are Back, Mag 7 Showdown, Zuck on Tilt, Apple's Fumble, GENIUS Act passes Senate
- every mention in 2025, scene by scene →
2024 10 mentions in 4 episodes 3 per episode
- GPT-4o launches, Glue demo, Ohalo breakthrough, Druck's Argentina bet, did Google kill Perplexity?
- Sam Altman: Getting Fired (and Re-Hired) by OpenAI, Agents, AI Copyright issues
- Hurricane fallout, AlphaFold, Google breakup, Trump surge, VC giveback, TikTok survey
- Dave Ricks, CEO of Eli Lilly | The All-In Interview
- every mention in 2024, scene by scene →
Everything said about Isomorphic Labs, oldest first
May 10, 2024 neutral
Friedberg: Google kept AlphaFold 3 proprietary instead of open-sourcing the code
“They've basically kept all the IP for AlphaFold III in Isomorphic. So Google is going to monetize the heck out of this capability. And what they made available was not open source code, but a web-based viewer that scientists for, quote, non-commercial purposes…”
May 17, 2024 bullish
May 17, 2024 bullish
Sep 12, 2025 bullish
Hassabis expects Isomorphic Labs to enter pre-clinical drug phase in 2026
“We're building up the platform right now, and it's, ah, we have great partnerships with Eli Lilly, I think you had, ah, the CEO speaking earlier, and Novartis, which are fantastic, and our own internal drug programs, and I think we'll be entering sort of pre-c…”